Mau E. Poh
Kuala Lumpur, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Advancing Precision Medicine in Non-Small Cell Lung Cancer Diagnostics in a Southeast Asian Country.
Advancing Precision Medicine in Non-Small Cell Lung Cancer Diagnostics in a Southeast Asian Country.
Journal: Cancer management and research
Published: October 29, 2025
Aspergillus fumigatus Sensitization Is Associated With High-Risk Bronchiectasis.
Journal: Chest
Published: August 25, 2025
Aspergillus fumigatus Sensitization Is Associated With High-Risk Bronchiectasis.
Journal: Chest
Published: August 25, 2025
Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer.
Journal: Translational lung cancer research
Published: March 14, 2024
Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.
Journal: American journal of respiratory and critical care medicine
Published: January 25, 2024
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Journal: Translational lung cancer research
Published: November 11, 2023
Pathological complete response in an advance stage IIIB non-small cell lung cancer secondary to neoadjuvant osimertinib targeted therapy: A case report and review of literature.
Journal: Respirology case reports
Published: April 22, 2023
Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers.
Journal: BMC cancer
Published: November 19, 2022
Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country.
Journal: Cancer management and research
Published: October 18, 2022
Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia.
Journal: Cancer management and research
Published: March 11, 2022
Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD.
Journal: The European respiratory journal
Published: March 09, 2022
Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country.
Journal: Thoracic cancer
Published: January 27, 2022
Last Updated: 09/26/2026